#USA #Fayetteville #Cardiovascular #HealthTech #HeartX

HeartX Introduces Innovative Startups for 2025 Accelerator Program

The HeartX Cardiovascular Accelerator, powered by HealthTech Arkansas and MedAxiom, recently unveiled the seven healthcare startups deemed most promising for the 2025 program. This initiative aims to bolster the development of groundbreaking technologies in cardiovascular care, granting startups unparalleled access to clinical resources and expertise.

HeartX serves as a unique platform designed to facilitate pilot projects within hospitals, enabling startups to test their innovations in a real-world clinical setting. This hands-on approach not only enhances the product development cycle but also fosters collaboration between startups and healthcare professionals, ultimately enriching patient care methodologies.

The Selected Startups

The 2025 cohort features the following seven groundbreaking companies:

1. CardiaCare – Los Angeles, CA, USA
CardiaCare is pioneering a revolutionary non-invasive therapy for managing atrial fibrillation (AFib). Their wearable device utilizes a combination of neuromodulation therapy and AI-driven cardiac monitoring to offer a personalized at-home management solution. Early results have indicated significant potential for reducing AFib recurrence and delivering long-term cardiac monitoring benefits.

2. CathVision – Copenhagen, Denmark
The ECGenius system by CathVision is engineered to enhance the precision of cardiac interventions. It boasts high-fidelity, noise-cancelling signals that assist clinicians in navigating ablation procedures. Additionally, the PFAnalyzer™ and FaST™ mapping tools provide critical real-time feedback, allowing for more data-informed treatment decisions.

3. Dopl Technologies – Bothell, WA, USA
Dopl Technologies aims to revolutionize access to diagnostic imaging through its Traverse™ telerobotic ultrasound system. This solution not only facilitates real-time remote cardiac imaging but also links healthcare institutions with on-demand sonographers, thereby addressing significant workforce shortages in underserved regions.

4. Echopoint Medical – London, England
The iKOr™ microcatheter system by Echopoint Medical aims to redefine coronary disease diagnostics. By integrating seamlessly into existing cath lab workflows, cardiologists receive immediate, actionable insights, enabling tailored patient care right at the treatment point.

5. FibriCheck – New York City, NY, USA
As an FDA-cleared platform, FibriCheck specializes in remote AFib detection using advanced photoplethysmography technology. Patients can effectively monitor their heart rhythm via their smartphones, while healthcare providers benefit from sophisticated reporting and analytical tools designed to streamline clinical workflows.

6. HEARTio – Pittsburgh, PA, USA
HEARTio harnesses AI to analyze 12-lead ECGs, providing critical insights for coronary disease assessment. Its API integration offers expedited access to actionable information, enhancing risk stratification and optimizing patient management strategies for healthcare providers.

7. LiveMetric – Luxembourg, Luxembourg
LiveMetric has developed a cuff-free, wearable monitoring device that measures blood pressure and heart rate with hospital-grade accuracy. Their technology delivers continuous, non-invasive hemodynamic data across numerous cardiovascular conditions, making it a significant asset for both patients and clinicians.

A Milestone for HeartX

According to Jeff Stinson, the Director of HealthTech Arkansas, this selection marks the largest cohort in HeartX's history, reflecting the growing engagement from participating hospitals nationwide. Stinson stated, “The expanding geographic reach and service offerings of HeartX is a thrilling development for all involved.”

MedAxiom’s chief commercial officer, Dr. Joe Sasson, also emphasized the significance of this year's cohort, noting, “These innovative startups signify a transformative phase in cardiovascular healthcare. By bridging advanced technologies with practical clinical applications, we are setting the stage for enhanced patient outcomes.”

HeartX’s accelerator program is now in its eighth year and, for the fourth consecutive year, it has collaborated with MedAxiom to promote cardiovascular innovation through strategic partnerships.

To learn more about HeartX and the transformative work being done within the cardiovascular space, visit HeartXAccelerator.com.

About HealthTech Arkansas

HealthTech Arkansas champions innovation in healthcare through collaboration between provider organizations and emerging startups. Through the HeartX accelerator, the initiative actively recruits global startups that focus on cardiovascular health, providing essential clinical trials and pilot projects with leading cardiology practices.
For more, visit HealthTechArkansas.com.

About MedAxiom

MedAxiom is a key player in optimizing cardiovascular care by leveraging the insights and expertise of countless members across the cardiovascular community. By integrating smart data and efficient strategies, MedAxiom helps organizations pursue enhanced outcomes while maintaining lower costs and improved patient experiences. Learn more at MedAxiom.com.